Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Misoprostol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myofibroma 6 Neoplasm Metastasis 5 Leiomyoma 4 Hemorrhage 4 Blood Loss, Surgical 4 Uterine Cervical Neoplasms 1 Postoperative Hemorrhage 1 Postoperative Complications 1 Myoma 1 Diabetes Insipidus 1

Interventions

Cisplatin 180 Radiotherapy 81 Paclitaxel 80 Brachytherapy 74 Carboplatin 72 pembrolizumab 64 Bevacizumab 40 Surveys and Questionnaires 29 Colposcopy 29 Radiation 28 Gemcitabine 28 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 27 Topotecan 26 Magnetic Resonance Spectroscopy 23 Blood Specimen Collection 23 human papillomavirus vaccine, L1 type 16, 18 22 Nivolumab 21 Drug Therapy 21 Papillomavirus Vaccines 20 atezolizumab 19 Platinum 19 Radiotherapy, Intensity-Modulated 18 Biopsy 18 Docetaxel 17 Taxes 16 Cyclophosphamide 16 Early Intervention, Educational 15 1,2-diaminocyclohexaneplatinum II citrate 15 Methods 14 fludarabine 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06669533 2025-10-01

MISOPCx

University of Alabama at Birmingham

Phase NA Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡